Perspectives on cannabis as a substitute for opioid analgesics

被引:28
|
作者
Khan, Sara P. [1 ]
Pickens, Thomas A. [1 ]
Berlau, Daniel J. [1 ]
机构
[1] Regis Univ, Sch Pharm, Dept Pharmaceut Sci, 3333 Regis Blvd H-28, Denver, CO 80221 USA
关键词
analgesia; marijuana; mu-opioid receptor agonists; opioid-sparing effect; synthetic CB2 agonist; CROSS-SECTIONAL SURVEY; CANNOT TELL US; MEDICAL MARIJUANA; RECREATIONAL USERS; VAPORIZED CANNABIS; DRUG-INTERACTIONS; NEUROPATHIC PAIN; UNITED-STATES; THC; DELTA(9)-TETRAHYDROCANNABINOL;
D O I
10.2217/pmt-2018-0051
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
With the opioid epidemic reaching new heights in the USA, it has become critical to find suitable alternatives to opioids. Cannabis, an antinociceptive, is a strong contender to help patients reduce their opioid usage. A growing literature has been examining the complex effects cannabis has on pain relief and on opioid usage; whether it is a substitute for opioids or increases their use. This review explores the studies that compare cannabis-opioid interactions and presents some challenges of cannabis research and usage. The practical clinical pharmacology of cannabis as an analgesic, including the route of administration, safety and pharmacokinetics, are discussed to address the concerns, as well as possible solutions, of cannabis as a pain reliever.
引用
收藏
页码:191 / 203
页数:13
相关论文
共 50 条